🇺🇸 FDA

Intelligence · Patent portfolio

RIGEL PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for RIGEL PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
373
Expiring ≤24m
18

Quick answer

RIGEL PHARMACEUTICALS has 373 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 18 expire within 24 months — use filters for patent-cliff planning.

Page 5 of 8

  1. US 8796259

    N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8791136

    Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same

    Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8785449

    Carboxamide compounds and methods for using the same

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8785437

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8771648

    (Trimethoxyphenylamino) pyrimidinyl formulations

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8748597

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8741898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8735418

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8735400

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8729087

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8710223

    Protein kinase C inhibitors and uses thereof

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8697727

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8658669

    Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8652492

    Wet granulation using a water sequestering agent

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8642593

    2,4-pyrimidinediamine compounds and prodrugs and their uses

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8637038

    Methods for inhibiting allograft rejection

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8618331

    Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8618095

    2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8609650

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8575165

    Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8569340

    AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8563569

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8563559

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8563716

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8557806

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8557822

    Carboxamide, sulfonamide and amine compounds and methods for using the same

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8546433

    Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8546398

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8530466

    Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8530656

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8524901

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8518937

    Pyrimidinediamine kinase inhibitors

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8507675

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8497279

    Treatment for discoid lupus

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8492373

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8486935

    Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8481521

    Methods of treating cell proliferative disorders

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8476263

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8445485

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8431594

    Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8420659

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8415365

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8410093

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8410266

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8399472

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8394951

    Protein kinase C inhibitors and uses thereof

    Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8389557

    Triazole derivatives useful as Axl inhibitors

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8389515

    2,4-pyrimidinediamine compounds and prodrugs and their uses

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does RIGEL PHARMACEUTICALS have?

373 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RIGEL PHARMACEUTICALS patents expire?

18 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.